Clinical Trial Update: Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating supramaximal titrated inhibition of the RAAS pathway in patients with dilated cardiomyopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy

Snippet

Sponsor: Xijing Hospital | Conditions: Dilated Cardiomyopathy | Phase 4 | Status: COMPLETED